Neuronal substrate of cognitive impairment in post-stroke dementia.

large GCH1 mutation positive family with dopa responsive dystonia: confusing the picture? J Neurol Neurosurg Psychiatry 2002; 72: 801–4. Grünewald A, Kasten M, Ziegler A, Klein C. Next-generation phenotyping using the parkin example: time to catch up with genetics. JAMA Neurol 2013; 70: 1186–91. Klepitskaya O, Neuwelt AJ, Nguyen T, Leehey M. Primary dystonia misinterpreted as Parkinson disease: video case presentation and practical clues. Neurol Clin Practice 2013; 3: 469–74. Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R. Responsiveness to levodopa in epsilon-sarcoglycan deletions. Mov Disord 2009; 24: 425–8. Mencacci NE, Isaias IU, Reich MM, Plagnol V, Polke JM, Bras J, et al. Parkinson’s disease in GTP cyclohydrolase-1 mutation carriers. Brain 2014. Tadic V, Kasten M, Bruggemann N, Stiller S, Hagenah J, Klein C. Doparesponsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol 2012; 69: 1–5.